Self-assembled chitosan-ceramide nanoparticle for enhanced oral delivery of paclitaxel

Pharmaceutical Research

Volumn 31, Issue 11, 2014, Pages 3019-3030

  Battogtokh, Gantumur ^a   Ko, Young Tag ^a  

^a Gachon University   (South Korea)

Author keywords

ceramide; chitosan; paclitaxel; polymeric nanoparticle; self assembling

Indexed keywords

CERAMIDE; CHITOSAN; DELAYED RELEASE FORMULATION; DRUG CARRIER; EMULSION; NANOPARTICLE; PACLITAXEL;

ANIMAL; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; EMULSION; HUMAN; MCF 7 CELL LINE; MELANOMA, EXPERIMENTAL; MOUSE; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PROCEDURES; TUMOR CELL LINE;

ADMINISTRATION, ORAL; ANIMALS; CELL LINE, TUMOR; CERAMIDES; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EMULSIONS; HUMANS; MCF-7 CELLS; MELANOMA, EXPERIMENTAL; MICE; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE;

EID: 84931060566     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1395-2     Document Type: Article

References (39)

1. Yoo JW, Doshi N, Mitragotri S. Adaptive Micro and Nanoparticles: Temporal Control Over Carrier Properties to Facilitate Drug Delivery. Adv Drug Deliv Rev. 2011;63(14-15):1247-56.
2. Kedar U, Phutane P, Shidhaye S, Kadam V. Advances in Polymeric Micelles for Drug Delivery and Tumor Targeting. Nanomedicine. 2010;6(6):714-29.
3. Siddiqui IA, Adhami VM, Chamcheu JC, Mukhtar H. Impact of Nanotechnology in Cancer: Emphasis on Nanochemoprevention. Int J Nanomedicine. 2012;7:591-605.
4. Chen MC, Mi FL, Liao ZX, Hsiao CW, Sonaje K, Chung MF, et al. Recent Advances in Chitosan-based Nanoparticles for Oral Delivery of Macromolecules. Adv Drug Deliv Rev. 2013;65(6):865-79.
5. Iqbal J, Sarti F, Perera G, Bernkop-Schnurch A. Development and in vivo Evaluation of an Oral Drug Delivery System for Paclitaxel. Biomaterials. 2011;32(1):170-5.
6. Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC. Nanoparticles in Medicine: Therapeutic Applications and Developments. Clin Pharmacol Ther. 2008;83(5):761-9.
7. Gamboa JM, Leong KW. In vitro and in vivo Models for the Study of Oral Delivery of Nanoparticles. Adv Drug Deliv Rev. 2013;65(6):800-10.
8. Thanou MM, Kotze AF, Scharringhausen T, Luessen HL, de Boer AG, Verhoef JC, et al. Effect of Degree of Quaternization of N-Trimethyl Chitosan Chloride for Enhanced Transport of Hydrophilic Compounds Across Intestinal Caco-2 Cell Monolayers. J Control Release. 2000;64(1-3):15-25.
9. Leong KW, Sung HW. Nanoparticle-and Biomaterials-Mediated Oral Delivery for Drug, Gene, and Immunotherapy. Adv Drug Deliv Rev. 2013;65(6):757-8.
10. Hejazi R, Amiji M. Chitosan-Based Gastrointestinal Delivery Systems. J Control Release. 2003;89(2):151-65.
11. Jang MK, Jeong YI, Nah JW. Characterization and Preparation of Core-Shell Type Nanoparticle for Encapsulation of Anticancer drug. Colloids Surf B: Biointerfaces. 2010;81(2):530-6.
12. Kim K, Kwon S, Park JH, Chung H, Jeong SY, Kwon IC, et al. Physicochemical Characterizations of Self-Assembled Nanoparticles of Glycol Chitosan-Deoxycholic Acid Conjugates. Biomacromolecules. 2005;6(2):1154-8.
13. Liu CG, Desai KG, Chen XG, Park HJ. Linolenic Acid-Modified Chitosan for Formation of Self-Assembled Nanoparticles. J Agric Food Chem. 2005;53(2):437-41.
14. Chen XG, Lee CM, Park HJ. O/W Emulsification for the Self-Aggregation and Nanoparticle Formation of Linoleic Acid-Modified Chitosan in the Aqueous System. J Agric Food Chem. 2003;51(10):3135-9.
15. Zhang J, Chen XG, Li YY, Liu CS. Self-Assembled Nanoparticles Based on Hydrophobically Modified Chitosan as Carriers for Doxorubicin. Nanomedicine. 2007;3(4):258-65.
16. Wang XY, Zhang L, Wei XH, Wang Q. Molecular Dynamics of Paclitaxel Encapsulated by Salicylic Acid-Grafted Chitosan Oligosaccharide Aggregates. Biomaterials. 2013;34(7):1843-51.
17. Kim S, Shi Y, Kim JY, Park K, Cheng JX. Overcoming the Barriers in Micellar Drug Delivery: Loading Efficiency, in vivo Stability, and Micelle-Cell Interaction. Expert Opin Drug Deliv. 2010;7(1):49-62.
18. Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z. Polysaccharides-Based Nanoparticles as Drug Delivery Systems. Adv Drug Deliv Rev. 2008;60(15):1650-62.
19. Torchilin VP. Micellar Nanocarriers: Pharmaceutical Perspectives. Pharm Res. 2007;24(1):1-16.
20. Saddoughi SA, Song P, Ogretmen B. Roles of Bioactive Sphingolipids in Cancer Biology and Therapeutics. Subcell Biochem. 2008;49:413-40.
21. Cho HJ, Yoon HY, Koo H, Ko SH, Shim JS, Lee JH, et al. Self-Assembled Nanoparticles Based on Hyaluronic Acid-Ceramide (HA-CE) and Pluronic (R) for Tumor-Targeted Delivery of Docetaxel. Biomaterials. 2011;32(29):7181-90.
22. Patel MP, Patel RR, Patel JK. Chitosan Mediated Targeted Drug Delivery System: a Review. J Pharm Pharm Sci. 2010;13(4):536-57.
23. Lee E, Lee J, Lee IH, Yu M, Kim H, Chae SY, et al. Conjugated Chitosan as a Novel Platform for Oral Delivery of Paclitaxel. J Med Chem. 2008;51(20):6442-9.
24. Lee CM, Jang D, Kim J, Cheong SJ, Kim EM, Jeong MH, et al. Oleyl-Chitosan Nanoparticles Based on a Dual Probe for Optical/MR Imaging in vivo. Bioconjug Chem. 2011;22(2):186-92.
25. Zhao T, Chen H, Dong Y, Zhang J, Huang H, Zhu J, et al. Paclitaxel-Loaded Poly (Glycolide-Co-Epsilon-Caprolactone)-b-D-Alpha-Tocopheryl Polyethylene Glycol 2000 Succinate Nanoparticles for Lung Cancer Therapy. Int J Nanomedicine. 2013;8:1947-57.
26. Gil ES, Wu L, Xu L, Lowe TL. Beta-Cyclodextrin-Poly (Beta-Amino Ester) Nanoparticles for Sustained Drug Delivery Across the Blood-Brain Barrier. Biomacromolecules. 2012;13(11):3533-41.
27. Jiang GB, Quan D, Liao K, Wang H. Novel Polymer Micelles Prepared from Chitosan Grafted Hydrophobic Palmitoyl Groups for Drug Delivery. Mol Pharm. 2006;3(2):152-60.
28. Toh EK, Chen HY, Lo YL, Huang SJ, Wang LF. Succinated Chitosan as a Gene Carrier for Improved Chitosan Solubility and Gene Transfection. Nanomedicine. 2011;7(2):174-83.
29. Durrieu VPJ, Passas R, Gandini A. Cryo-TEM and Image Analysis of Polymer Nanoparticle Dispersions. Microsc Anal. 2004;18(1):19-21.
30. Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, et al. Hypersensitivity Reactions from Taxol. J Clin Oncol. 1990;8(7):1263-8.
31. Ramesan RM, Sharma CP. Challenges and Advances in Nanoparticle-Based Oral Insulin Delivery. Expert Rev Med Devices. 2009;6(6):665-76.
32. Kawashima Y, Yamamoto H, Takeuchi H, Kuno Y. Mucoadhesive DL-Lactide/Glycolide Copolymer Nanospheres Coated with Chitosan to Improve Oral Delivery of Elcatonin. Pharm Dev Technol. 2000;5(1):77-85.
33. Ensign LM, Cone R, Hanes J. Oral Drug Delivery with Polymeric Nanoparticles: the Gastrointestinal Mucus Barriers. Adv Drug Deliv Rev. 2012;64(6):557-70.
34. Aktas Y, Yemisci M, Andrieux K, Gursoy RN, Alonso MJ, Fernandez-Megia E, et al. Development and Brain Delivery of Chitosan-PEG Nanoparticles Functionalized with the Monoclonal Antibody OX26. Bioconjug Chem. 2005;16(6):1503-11.
35. Miron T, Wilchek M. A Simplified Method for the Preparation of Succinimidyl Carbonate Polyethylene Glycol for Coupling to Proteins. Bioconjug Chem. 1993;4(6):568-9.
36. Morpurgo M, Bayer EA, Wilchek M. N-hydroxysuccinimide Carbonates and Carbamates are Useful Reactive Reagents for Coupling Ligands to Lysines on Proteins. J Biochem Biophys Methods. 1999;38(1):17-28.
37. Yokoyama M, Opanasopit P, Okano T, Kawano K, Maitani Y. Polymer Design and Incorporation Methods for Polymeric Micelle Carrier System Containing Water-Insoluble Anti-Cancer Agent Camptothecin. J Drug Target. 2004;12(6):373-84.
38. Li H, Huo M, Zhou J, Dai Y, Deng Y, Shi X, et al. Enhanced Oral Absorption of Paclitaxel in N-deoxycholic Acid-N, O-hydroxyethyl Chitosan Micellar system. J Pharm Sci. 2010;99(11):4543-53.
39. Gelderblom H, Verweij J, Nooter K, Sparreboom A. Cremophor EL: the Drawbacks and Advantages of Vehicle Selection for Drug Formulation. Eur J Cancer. 2001;37(13):1590-8.